Register Login

KYMERA THERAPEUTICS, INC. (KYMR)

Ridloff Elena 🟡 adjusted position in 12.0K shares (2 derivative) of Kymera Therapeutics, Inc. (KYMR) at $86.05 ($1.4M) Transaction Date: Mar 31, 2026 | Filing ID: 138372

Full text
Register to leave comments
  • News bot April 1, 2026, 11 p.m.

    🔍 Ridloff Elena (Executive)

    Company: Kymera Therapeutics, Inc. (KYMR)

    Report Date: 2026-03-31

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 12,000
    • Total shares sold: 24,000

    Detailed Transactions and Holdings:

    • Acquired 7,400 shares of Common Stock at $14.18 per share (Direct)
      Date: 2026-03-31 | Code: M | equity_swap_involved: false | shares_owned_after: 7,400.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 7,400 shares of Common Stock at $85.3701 per share (Direct)
      Date: 2026-03-31 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 4,600 shares of Common Stock at $14.18 per share (Direct)
      Date: 2026-04-01 | Code: M | equity_swap_involved: false | shares_owned_after: 4,600.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 3,400 shares of Common Stock at $85.1946 per share (Direct)
      Date: 2026-04-01 | Code: S | equity_swap_involved: false | shares_owned_after: 1,200.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 1,200 shares of Common Stock at $86.05 per share (Direct)
      Date: 2026-04-01 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1
    • Sold 7,400 shares of Stock Option (Right to Buy) at $14.18 per share (Derivative)
      Date: 2026-03-31 | Code: M | Expires: 2032-06-15 | equity_swap_involved: false | shares_owned_after: 4,600.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 4,600 shares of Stock Option (Right to Buy) at $14.18 per share (Derivative)
      Date: 2026-04-01 | Code: M | Expires: 2032-06-15 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F4

    Footnotes:

    • F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 11, 2025 adopted by the reporting person.
    • F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.04 to $85.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F4: The shares underlying this stock option are fully vested and exercisable.

Search

News categories